46 research outputs found

    Glass Transition Phenomena Semiannual Status Report

    Get PDF
    Multiple glass transitions, heat capacities, and equation of state properties of polymer system

    L’émergence d’une histoire environnementale interdisciplinaire. Une approche conjointe de l’HolocĂšne tardif

    No full text
    L’histoire, en tant que discipline, traverse une phase de transition. D’une part, de nouveaux types d’indices (palynologiques, dendrologiques, glaciologiques, ostĂ©o- logiques, archĂ©ogĂ©nĂ©tiques, etc.) sont disponibles, mais beaucoup d’historiens demeurent rĂ©ticents Ă  les utiliser, faute d’avoir Ă©tĂ© formĂ©s pour le faire. D’autre part, la situation mondiale actuelle, particuliĂšrement critique, marquĂ©e par des changements climatiques et des perturbations Ă©cosystĂ©miques sans prĂ©cĂ©dent ainsi que par l’émergence (non sans lien avec ces dĂ©rĂšglements) de maladies hautement transmissibles, incite Ă  se tourner vers le passĂ©, Ă  la recherche de parallĂšles signi- fiants et de boussoles susceptibles de nous guider. Des professionnels d’autres disciplines – notamment de la mĂ©decine, des sciences de l’environnement et de l’économie – se sont attelĂ©s Ă  cette tĂąche en proposant au grand public des « leçons historiques ». Les historiens, quant Ă  eux, participent encore trop peu souvent aux dĂ©bats sur les dĂ©fis du prĂ©sent et le futur de la planĂšte qui en dĂ©coule, alors mĂȘme que ceux-ci captivent l’opinion et contribuent effectivement Ă  tracer les contours de notre avenir

    The first Team Haemophilia Education meeting, 2015, Amsterdam, The Netherlands

    No full text
    Haemophilia remains a complex disorder to diagnose and manage, requiring close cooperation between multidisciplinary healthcare professionals. There are still many unmet challenges in haemophilia care. The first Team Haemophilia Education (THE) meeting, held on 7-8 May 2015 in Amsterdam, The Netherlands, aimed to promote the optimal care of haemophilia patients through education of the multidisciplinary treatment team. This was achieved by reviewing the latest developments in haemophilia management, considering how these can be implemented in the clinic to improve patient care and providing a platform for networking and debate for all haemophilia treatment team members. Haemophilia treatment centres from several countries were asked to complete a premeeting online questionnaire to establish the biggest challenges that they face when managing patients. The concerns expressed were used to develop the agenda, which comprised a combination of formal presentations, case studies and informal workshops covering such topics as pharmacokinetics, laboratory assays and tailoring of treatment to individual patients. This report is a summary of the key developments in haemophilia care presented by various investigators and healthcare professionals at THE meeting 2015

    Differences between familial and sporadic dilated cardiomyopathy: ESC EORP Cardiomyopathy & Myocarditis registry

    Get PDF
    Aims: Dilated cardiomyopathy (DCM) is a complex disease where genetics interplay with extrinsic factors. This study aims to compare the phenotype, management, and outcome of familial DCM (FDCM) and non-familial (sporadic) DCM (SDCM) across Europe. Methods and results: Patients with DCM that were enrolled in the prospective ESC EORP Cardiomyopathy & Myocarditis Registry were included. Baseline characteristics, genetic testing, genetic yield, and outcome were analysed comparing FDCM and SDCM; 1260 adult patients were studied (238 FDCM, 707 SDCM, and 315 not disclosed). Patients with FDCM were younger (P\ua0<\ua00.01), had less severe disease phenotype at presentation (P\ua0<\ua00.02), more favourable baseline cardiovascular risk profiles (P\ua0 64\ua00.007), and less medication use (P\ua0 64\ua00.042). Outcome at 1\ua0year was similar and predicted by NYHA class (HR 0.45; 95% CI [0.25\u20130.81]) and LVEF per % decrease (HR 1.05; 95% CI [1.02\u20131.08]. Throughout Europe, patients with FDCM received more genetic testing (47% vs. 8%, P\ua0<\ua00.01) and had higher genetic yield (55% vs. 22%, P\ua0<\ua00.01). Conclusions: We observed that FDCM and SDCM have significant differences at baseline but similar short-term prognosis. Whether modification of associated cardiovascular risk factors provide opportunities for treatment remains to be investigated. Our results also show a prevalent role of genetics in FDCM and a non-marginal yield in SDCM although genetic testing is largely neglected in SDCM. Limited genetic testing and heterogeneity in panels provides a scaffold for improvement of guideline adherence
    corecore